EndoQuest Robotics recently announced the completion of the first procedure performed by a gastroenterologist in its PARADIGM trial.
Distalmotion announced today that it received FDA 510(k) clearance for the use of its Dexter robotic surgery system in hysterectomy.
For many stroke survivors, even the smallest number of steps carries enormous weight. Each movement becomes a reminder of lost coordination, muscle weakness, and physical vulnerability.
Virtuoso Surgical announced today that it received FDA breakthrough device designation for bladder lesion removal with its surgical robot.
A team of researchers at the University of Macau in China recently developed new soft magnetic robots that can climb inverted surfaces and move in complex environments, which could allow them to deliver drugs to specific locations in the GI tract.
Mendaera today announced the world’s first procedures performed with its Focalist handheld robotic surgery system.
The FDA’s clearance of LIBERTY follows the completion of Microbot’s pivotal trial in April 2025, achieving a 100% success rate in robotic navigation.
Researchers at University of Tsukuba have demonstrated for the first time that brain regions responsible for high-level motor planning and preparation, such as the premotor cortex, are activated when a cyborg-type robot is volitionally controlled.
Lifeward (Nasdaq:LFWD) announced today that it received CE mark approval for its ReWalk 7 personal exoskeleton.
Surgerii Robotics announced on LinkedIn today that its Shurui single-port surgical robot garnered CE mark approval in Europe.